🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsGeneric oral semaglutide — 12 month update Page 4

Generic oral semaglutide — 12 month update

TrialNerd_Beth Mon, Feb 2, 2026 at 11:34 PM 24 replies 1,302 viewsPage 4 of 5
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Feb 4, 2026 at 12:22 PM#16

From the other side of the consultation, briefly. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Feb 4, 2026 at 3:22 PM
43 18pete_nash, hank_denver, carlos_SATX and 40 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Feb 4, 2026 at 2:55 PM#17
FDA_TrackerJim said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Agreed, though "tolerable" needs defining. A dose you tolerate by eating almost nothing is not tolerated, it is being paid for somewhere else — usually in lean mass, sometimes in adherence three months later.

Last edited: Feb 4, 2026 at 4:55 PM
42 17Dr.PathRoch, mona_PHX, andrew_nyc and 39 others
Reply Quote Save Share Report
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Feb 4, 2026 at 5:28 PM#18
FDA_TrackerJim said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

This is exactly what I could not find anywhere else. Sending this to two other people who asked me the same thing last week.

Last edited: Feb 4, 2026 at 10:28 PM
41 16rachel_ABQ, traveltech_sara, AttorneyGrant and 38 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Feb 4, 2026 at 8:01 PM#19

Adding the clinical framing, because it changes how the question reads. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

40 15tom_AK, josh_phd_bmore, roxy_nash and 37 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Feb 4, 2026 at 10:34 PM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. No action needed from anybody.

Last edited: Feb 5, 2026 at 12:34 AM
18 18PurityPaulOR, MaxMetOK, MounjBrad and 15 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register